Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
ABBV-8E12
Placebo solution for IV infusion on Day 15
Locations
42
United States
Univ Alabama-Birmingham /ID# 165522
Birmingham, Alabama, United States
Mayo Clinic Arizona /ID# 165521
Phoenix, Arizona, United States
Cedars-Sinai Medical Center /ID# 165567
Beverly Hills, California, United States
Usc /Id# 165529
Los Angeles, California, United States
University of California, Los Angeles /ID# 165669
Los Angeles, California, United States
University of California, San /ID# 165560
San Diego, California, United States
Start Date
January 24, 2018
Primary Completion Date
December 13, 2019
Completion Date
December 13, 2019
Last Updated
February 3, 2021
NCT05121012
NCT07136844
NCT02839642
NCT02365922
NCT02778607
NCT02531360
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions